1. Home
  2. STVN vs COOP Comparison

STVN vs COOP Comparison

Compare STVN & COOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STVN
  • COOP
  • Stock Information
  • Founded
  • STVN 1949
  • COOP 1994
  • Country
  • STVN Italy
  • COOP United States
  • Employees
  • STVN N/A
  • COOP N/A
  • Industry
  • STVN Containers/Packaging
  • COOP Finance: Consumer Services
  • Sector
  • STVN Consumer Discretionary
  • COOP Finance
  • Exchange
  • STVN Nasdaq
  • COOP Nasdaq
  • Market Cap
  • STVN 5.7B
  • COOP 5.3B
  • IPO Year
  • STVN 2021
  • COOP N/A
  • Fundamental
  • Price
  • STVN $20.93
  • COOP $133.56
  • Analyst Decision
  • STVN Buy
  • COOP Buy
  • Analyst Count
  • STVN 7
  • COOP 10
  • Target Price
  • STVN $26.93
  • COOP $111.00
  • AVG Volume (30 Days)
  • STVN 372.3K
  • COOP 1.2M
  • Earning Date
  • STVN 03-06-2025
  • COOP 04-23-2025
  • Dividend Yield
  • STVN 0.28%
  • COOP N/A
  • EPS Growth
  • STVN N/A
  • COOP 39.59
  • EPS
  • STVN 0.45
  • COOP 10.19
  • Revenue
  • STVN $1,143,012,735.00
  • COOP $2,225,000,000.00
  • Revenue This Year
  • STVN $8.60
  • COOP $21.30
  • Revenue Next Year
  • STVN $12.43
  • COOP $10.97
  • P/E Ratio
  • STVN $46.99
  • COOP $13.11
  • Revenue Growth
  • STVN 1.72
  • COOP 24.02
  • 52 Week Low
  • STVN $16.56
  • COOP $74.49
  • 52 Week High
  • STVN $31.61
  • COOP $137.60
  • Technical
  • Relative Strength Index (RSI)
  • STVN 50.35
  • COOP 79.72
  • Support Level
  • STVN $20.11
  • COOP $103.84
  • Resistance Level
  • STVN $21.21
  • COOP $108.77
  • Average True Range (ATR)
  • STVN 1.00
  • COOP 3.77
  • MACD
  • STVN -0.05
  • COOP 2.89
  • Stochastic Oscillator
  • STVN 35.51
  • COOP 89.50

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About COOP Mr. Cooper Group Inc.

Mr. Cooper Group Inc is a home loan servicer. The company focuses on delivering a variety of servicing and lending products. It has operating segments namely Servicing segment which performs operational activities on behalf of investors or owners of the underlying mortgages and mortgage servicing rights, including collecting and disbursing borrower payments, investor reporting, and customer service, The Originations segment originates residential mortgage loans through a direct-to-consumer channel, which provides refinance options for existing customers, and through a correspondent channel, which purchases or originates loans from mortgage bankers and brokers, and the Corporate segment. The Servicing segment of the company generates maximum revenue.

Share on Social Networks: